Posts in category

PDL Practice Alert


During your healthcare career, you may receive a regulatory notification Regulatory notifications are a mechanism for the public to raise any concerns about their healthcare experience and are an integral …

From 1 October 2024, therapeutic vapes with a nicotine concentration of 20mg/mL or less will be available in pharmacies to patients 18 years or over without a prescription. Date of …

PDL has some advice for pharmacists on lawfully supplying vapes for smoking cessation Pharmacists would be aware of the down scheduling of some nicotine vaping or e-cigarette products to S3 …

PDL has advice for pharmacists in NSW and the ACT providing the oral contraceptive resupply service NSW pharmacists The oral contraceptive resupply component of the NSW Pharmacy Trial ceased on …

This alert provides insights into the common causes of wrong patient incidents and provides suggestions preventative strategies PDL has recently released the Practice Alert ‘Be aware or beware of wrong …

PDL has advice for South Australian pharmacists about the recent change relating to administering medicines Following the recent direction from the chief pharmacist department of Health SA, PDL advises that …

PDL offers advice for pharmacists regarding Wegovy (semaglutide) following a number of incident reports Pharmacists are likely aware that Wegovy (semaglutide) is now available in Australia. The PDL Professional Officers …

The wrong patient incident type is a subset of dispensing incidents that continue to be highly reported to PDL   This almost entirely preventable error occurs primarily in community pharmacies; …

As of 16 August, SafeScript has introduced updated features designed to enhance the user experience The update that relates to pharmacists is the improved visibility of high-risk messages which now …

Pharmacies in NSW providing a UTI service must meet the requirements of the authority  Under this authority, pharmacies are required to maintain an up-to-date UTI service listing on the National …

The Pharmacy Board of Australia’s revised Guidelines on compounding of medicines is a timely reminder of the responsibilities of pharmacists when compounding, says PDL The guidelines will take effect from …

Information from the Pharmaceutical Services Unit (PSU)   The PDL Professional Officers often receive enquiries relating to the validity of psychostimulant prescriptions written for NSW patients.   The Pharmaceutical Services …